Tikehau Capital, Sprim join forces with new S'pore-based life sciences VC fund
Singapore
LIFE science startups hoping for a big break can now look to a new Singapore-based cash cow for funding.
European asset manager Tikehau Capital and Sprim Ventures, the venture arm of global healthcare consultancy Sprim, have teamed up to launch a venture capital (VC) fund for early-stage investments.
TRENDING NOW
OCBC Q3 profit rises 3% to S$2.04 billion, slightly above expectations
Stocks to watch: OCBC, IHH Healthcare, FLCT, SingPost, Koh Brothers Eco Engineering
From legacy to launch: Francis Yeoh and Yeoh Pei Xien on family unity and YTL’s next‑gen ventures
Wealthy Indonesians snap up government bonds as yields near 8%: OCBC